R T Meijer
Overview
Explore the profile of R T Meijer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meijer R, Surachno S, Yong S, Bemelman F, Florquin S, ten Berge I, et al.
Clin Exp Immunol
. 2003 Aug;
133(3):485-92.
PMID: 12930378
T3/4.A is a non-mitogenic murine IgA mAb to human CD3 that was selected for clinical studies to provide an alternative for the mitogenic, T cell-activating, therapeutic mAb OKT3. Previously, we...
2.
Meijer R, Koopmans R, ten Berge I, Schellekens P
J Pharmacol Exp Ther
. 2001 Dec;
300(1):346-53.
PMID: 11752135
Therapy with monoclonal antibodies (mAbs) is characterized by a molar ratio of receptor to drug that is higher than usual in pharmacotherapy. As a consequence, changes in the amount of...
3.
Meijer R, Keur I, Surachno S, ten Berge I, Schellekens P
Transplant Proc
. 2001 May;
33(3):2196-7.
PMID: 11377501
No abstract available.
4.
Meijer R, Yong S, ten Berge I, van Lier R, Schellekens P
Clin Exp Immunol
. 2001 Apr;
123(3):511-9.
PMID: 11298141
CLB T3/4.A is a non FcR-binding CD3 mAb of the murine IgA isotype, which may be used as an alternative for the mitogenic OKT3 mAb in the treatment of acute...
5.
Meijer R, Yong S, Surachno S, ten Berge I, Schellekens P
Transplant Proc
. 2001 Mar;
33(1-2):1229-30.
PMID: 11267271
No abstract available.